Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
175
-
Total 13F shares, excl. options
-
32,493,276
-
Shares change
-
+1,041,191
-
Total reported value, excl. options
-
$301,726,227
-
Value change
-
+$10,099,072
-
Put/Call ratio
-
73%
-
Number of buys
-
93
-
Number of sells
-
-56
-
Price
-
$9.22
Significant Holders of ANAVEX LIFE SCIENCES CORP. - COM NEW (AVXL) as of Q2 2025
221 filings reported holding AVXL - ANAVEX LIFE SCIENCES CORP. - COM NEW as of Q2 2025.
ANAVEX LIFE SCIENCES CORP. - COM NEW (AVXL) has 175 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 32,493,276 shares
.
Largest 10 shareholders include BlackRock, Inc. (7,001,762 shares), VANGUARD GROUP INC (5,106,867 shares), STATE STREET CORP (2,948,808 shares), GEODE CAPITAL MANAGEMENT, LLC (2,019,795 shares), NWAM LLC (1,024,479 shares), TWO SIGMA INVESTMENTS, LP (973,269 shares), Invesco Ltd. (863,959 shares), TWO SIGMA ADVISERS, LP (823,400 shares), NORTHERN TRUST CORP (777,165 shares), and CHARLES SCHWAB INVESTMENT MANAGEMENT INC (709,616 shares).
This table shows the top 175 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.